Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of FKC889 in adults with relapsed or refractory precursor B-cell acute lymphoblastic leukemia
CTR20231342Phase 2Active
- Sponsor
- Fosun Kairos
- Start
- Aug 2023
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of FKC889 in B cell acute lymphoblastic leukemia (B-ALL), sponsored by Fosun Kairos. Started Aug 2023; status: active.
02
Drugs
FKC889
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on CTR20231342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231342.